April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
The Impact of Prostaglandin on the Biomechanical Properties of the Cornea in Patients with Open Angle Glaucoma and/or Ocular Hypertension
Author Affiliations & Notes
  • Roman Meda
    Biomedical Science, University of Montreal, Montreal, QC, Canada
  • Isabelle Brunette
    Ophthalmology, University of Montreal, Montreal, QC, Canada
    Ophthalmology, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
  • Paul Harasymowycz
    Ophthalmology, University of Montreal, Montreal, QC, Canada
    Ophthalmology, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
  • Footnotes
    Commercial Relationships Roman Meda, None; Isabelle Brunette, None; Paul Harasymowycz, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4236. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Roman Meda, Isabelle Brunette, Paul Harasymowycz; The Impact of Prostaglandin on the Biomechanical Properties of the Cornea in Patients with Open Angle Glaucoma and/or Ocular Hypertension. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4236. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine whether the use of topical prostaglandin analogs (PGAs) affects the biomechanical properties of the cornea based on the integrated analysis of the Reichert Ocular Response Analyzer (ORA), Goldmann tonometry and ultrasound pachymetry.

Methods: Seventy eyes of 35 patients, aged 40-85 years with open angle glaucoma and/or intraocular hypertension treated with topical PGAs were examined. Only refraction between -6.00D and +6.00D were included. Exclusion criteria: patients with any corneal disease, such as Fuchs corneal endothelial dystrophy, keratoconus or history of corneal trauma or surgery, as well as contact lens wear. Patients with stable glaucoma parameters and topical PGAs in both eyes were asked to discontinue the PGAs in the best eye (less damage on VF - better MD or lower max IOP if MD equal). The measurements were taken before PGAs cessation and repeated 6 weeks after cessation. Patients then restarted PGAs and measurements were repeated once more after 6 weeks. All measurements were performed by the same trained technician, with the same equipment and at the same time of day. The contralateral eye served as control eye in the statistical analyses. Goldmann tonometry was used to measure IOP, ultrasound pachymetry for CCT, and ORA for the biomechanical properties, including corneal hysteresis (CH). The hypothesis of no effect of discontinuation of PGAs on the biomechanical properties was examined by OLS regression with control for clustering within patients by Stata 12.1.

Results: A statistically significant change in corneal hysteresis of study eye was found between visit 1 (on PGA) & visit 2 (no PGA): CH increased by 1.07 with 95% CI (0.55; 1.59), with CH values of 8.97 (±1.62, p=0.05) & 10.00 (± 1.47, p=0.05), visit 1 & 2 respectively. As well, between visit 2 (no PGA) & visit 3 (PGA restarted): CH decreased by 0.47 with 95% CI (-1.22; 0.29), with CH values of 9.30 (±1.47, p=0.05) on visit 3. There was also a statistical difference between the study and control eyes on visit 2 (t=-2.29; p=0.03) and no statistical change between the study and control eyes on visit 1 & 3 (t=1.48; p=0.15) & (t=-1.04; p=0.33).

Conclusions: The topical prostaglandin medication affects the biomedical properties of the cornea and reduces corneal hysteresis. These changes should be taken into account when evaluating IOP lowering response to PGA medications.

Keywords: 503 drug toxicity/drug effects • 479 cornea: clinical science  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×